D-0444-2025 Class II Ongoing

Recalled by AsttraZeneca Pharmaceuticals LP — Wilmington, DE

FDA drug recall D-0444-2025 was initiated by AsttraZeneca Pharmaceuticals LP on May 14, 2025 and is designated Class II. Reason for recall: Defective delivery system The recall status is ongoing. Affected quantity: a) 807,837 canisters; b) 235,698 canisters.

Recall details

Product Type
Drugs
Report Date
May 28, 2025
Initiation Date
May 14, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 807,837 canisters; b) 235,698 canisters

Product description

Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .

Reason for recall

Defective delivery system

Distribution pattern

USA Nationwide

Code information

Lot#: a) 6270044C00, 6270040D00, 6270034E00, Exp Date 10/2026; 6270053C00, 6270045C00, 6270047C00, 6270056C00, 6270052C00, 6270063E00 Exp 11/30/2026; 6270064C00, 6270071D00, 6270075D00, 6270075F00 Exp Date 12/31/2026; 6270107C00, Exp Date 9/30/2027; b) Lot 6270019E00, Exp Date 7/31/2025; 6270021D00, Exp 8/31/2025; 6270095C00, Exp 2/28/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0444-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0444-2025. Report a data issue: hello@regdatalab.com.